Toll-like receptors (TLR) play a critical role in innate immunity response, and our recent study showed that the TT genotype of TLR3 rs3775290 was associated with a decreased risk for CHB, LC, and HCC [56]. This evidence concerns the gene TLR3 and hepatocellular carcinoma.